Low-Dose Naltrexone for Treating MS Symptoms (News)

The LDN Conference 2021: 4th - 6th June 2021

Up to 29 CME Credits Available + Sponsor, Exhibitor and Advertiser Opportunities.  [More Details]

Submitted by baileylynn_100964 on Sat, 03/06/2021 - 18:16

Low-Dose Naltrexone for Treating MS Symptoms

Verywell Health
05 January 2020

Low-dose naltrexone (LDN), a drug used to treat opioid addiction, is getting a lot of attention as an off-label treatment for multiple sclerosis (MS)—namely, for the reduction of symptoms and relapses. It's a popular treatment among MS patients, but scientific evidence supporting its use is just beginning to take shape.